Caprelsa (vandetanib)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 WARNINGS AND PRECAUTIONS Severe Skin Reactions (previously Skin Reactions and Stevens-Johnson Syndrome) Severe and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts